Rapid Improvement in Jaundice Using Transdermal Isosorbide Tape as a Nitric Oxide Donor in Two Adult Patients with Transplantation-associated Microangiopathy Related to Graft-versus-host Disease

Intern Med. 2022 Apr 15;61(8):1225-1230. doi: 10.2169/internalmedicine.7789-21. Epub 2021 Sep 25.

Abstract

Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-host disease (GVHD). Both patients were resistant to standard therapy for TAM and GVHD, which led to markedly elevated serum total bilirubin levels of 47.5 and 10.6 mg/dL, respectively. Transdermal isosorbide tape as a nitric oxide donor was applied to Patients 1 and 2 on post-transplantation days 60 and 66, respectively, which rapidly improved their jaundice after 1 day. This is the first report to describe the efficacy of transdermal isosorbide tape for adult patients with jaundice associated with TAM related to GVHD.

Keywords: endothelial cell injury; graft-versus-host disease (GVHD); liver dysfunction; nitric oxide donor (NO donor); transdermal isosorbide tape; transplantation-associated microangiopathy (TAM).

MeSH terms

  • Adult
  • Graft vs Host Disease* / complications
  • Graft vs Host Disease* / drug therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Isosorbide / therapeutic use
  • Jaundice*
  • Nitric Oxide Donors / therapeutic use
  • Transplantation, Homologous
  • Vascular Diseases*

Substances

  • Nitric Oxide Donors
  • Isosorbide